Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency.

Stem Cell Res Ther 2017 07 27;8(1):176. Epub 2017 Jul 27.

Department of Medical Sciences, University of Torino, Corso Dogliotti 14, I-10126, Torino, Italy.

Background: Argininosuccinate synthase (ASS)1 is a urea cycle enzyme that catalyzes the conversion of citrulline and aspartate to argininosuccinate. Mutations in the ASS1 gene cause citrullinemia type I, a rare autosomal recessive disorder characterized by neonatal hyperammonemia, elevated citrulline levels, and early neonatal death. Treatment for this disease is currently restricted to liver transplantation; however, due to limited organ availability, substitute therapies are required. Recently, extracellular vesicles (EVs) have been reported to act as intercellular transporters carrying genetic information responsible for cell reprogramming. In previous studies, we isolated a population of stem cell-like cells known as human liver stem cells (HLSCs) from healthy liver tissue. Moreover, EVs derived from HLSCs were reported to exhibit regenerative effects on the liver parenchyma in models of acute liver injury. The aim of this study was to evaluate whether EVs derived from normal HLSCs restored ASS1 enzymatic activity and urea production in hepatocytes differentiated from HLSCs derived from a patient with type I citrullinemia.

Methods: HLSCs were isolated from the liver of a patient with type I citrullinemia (ASS1-HLSCs) and characterized by fluorescence-activated cell sorting (FACS), immunofluorescence, and DNA sequencing analysis. Furthermore, their differentiation capabilities in vitro were also assessed. Hepatocytes differentiated from ASS1-HLSCs were evaluated by the production of urea and ASS enzymatic activity. EVs derived from normal HLSCs were purified by differential ultracentrifugation followed by floating density gradient. The EV content was analyzed to identify the presence of ASS1 protein, mRNA, and ASS1 gene. In order to obtain ASS1-depleted EVs, a knockdown of the ASS1 gene in HLSCs was performed followed by EV isolation from these cells.

Results: Treating ASS1-HLSCs with EVs from HLSCs restored both ASS1 activity and urea production mainly through the transfer of ASS1 enzyme and mRNA. In fact, EVs from ASS1-knockdown HLSCs contained low amounts of ASS1 mRNA and protein, and were unable to restore urea production in hepatocytes differentiated from ASS1-HLSCs.

Conclusions: Collectively, these results suggest that EVs derived from normal HLSCs may compensate the loss of ASS1 enzyme activity in hepatocytes differentiated from ASS1-HLSCs.

Download full-text PDF

Source
http://stemcellres.biomedcentral.com/articles/10.1186/s13287
Publisher Site
http://dx.doi.org/10.1186/s13287-017-0628-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531104PMC
July 2017
44 Reads

Publication Analysis

Top Keywords

evs derived
16
hepatocytes differentiated
16
urea production
12
derived normal
12
normal hlscs
12
ass1 gene
12
hlscs
10
ass1
10
human liver
8
production hepatocytes
8
patient type
8
activity urea
8
ass1 enzyme
8
enzymatic activity
8
argininosuccinate synthase
8
extracellular vesicles
8
stem cells
8
liver stem
8
hlscs restored
8
evs
8

References

(Supplied by CrossRef)

HI Woo et al.
Clin Chim Acta 2014

K Vaidyanathan et al.
Indian J Biochem Biophys 2013

K Engel et al.
Hum Mutat 2009

MB Herrera et al.
Stem Cells 2006

MB Herrera et al.
Hepatology 2013

JF Stoltz et al.
Stem Cells Int 2015

S Liu et al.
Int J Mol Sci 2016

M Tkach et al.
Cell 2016

J Ratajczak et al.
Leukemia 2006

H Valadi et al.
Nat Cell Biol 2007

MC Deregibus et al.
Blood 2007

Similar Publications